Home › Amyotrophic Lateral Sclerosis › Texas › Dallas
Amyotrophic Lateral Sclerosis clinical trials in Dallas, TX
5 studies for Amyotrophic Lateral Sclerosis are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
Recruiting
- The University of Texas Southwestern Medical Center, Dallas
ASSESS ALL ALS Study
RecruitingObservational studyHealthy volunteers welcome
- Texas Neurology, Dallas
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
Recruiting
- UT Southwestern Medical Center, Dallas
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
RecruitingPhase 3
- Texas Neurology, Dallas
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
RecruitingPhase 2
- Zydus US001, Dallas
About Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a nerve disease that weakens muscles and gets worse over time. Learn how to manage symptoms.
More about Amyotrophic Lateral Sclerosis on MedlinePlus
Amyotrophic Lateral Sclerosis trials in other cities
- Boston, MA19 studies
- Jacksonville, FL12 studies
- Philadelphia, PA12 studies
- Baltimore, MD11 studies
- San Diego, CA9 studies
- Chicago, IL9 studies
- San Francisco, CA8 studies
- New York City, NY8 studies
- St. Louis, MO8 studies
- Atlanta, GA7 studies
- Phoenix, AZ7 studies
- Houston, TX7 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer53 studies
- Metastatic Cancer44 studies
- Heart Failure42 studies
- Cancer (all types)40 studies
- Prostate Cancer39 studies
- Colorectal Cancer34 studies
- Obesity33 studies
- Ovarian Cancer31 studies
- Bladder Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.